Results 141 to 150 of about 1,611,491 (358)

Higher Hospitalization Rate and Impaired Quality of Life in the Presence of Severe Tricuspid Regurgitation in Patients With Newly Diagnosed Atrial Fibrillation: Is the Risk Real?

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2022
Sanghamitra Mohanty, Andrea Natale
doaj   +1 more source

Pacemaker Prevention Therapy in Drug–refractory Paroxysmal Atrial Fibrillation: Reliability of Diagnostics and Effectiveness of Prevention Pacing Therapy in Vitatron™ Selection® device [PDF]

, 2006
Introduction. Atrial fibrillation (AF), the most common and rising disorder of cardiac rhythm, is quite difficult to control and/or to treat. Non pharmacological therapies for AF may involve the use of dedicated pacing algorithms to detect and prevent ...
Dell’Orto, Simonetta, Greco, Enrico Maria, Terranova, Paolo, Terranova, Peppino, Valli, Paolo   +4 more
core   +2 more sources

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

Electrocardiographic manifestation of cardiac repolarization dispersion [PDF]

, 2019
Alterations of repolarization heterogeneity in the heart have been established as anAlterations of repolarization heterogeneity in the heart have been established as ...
Sedova Ksenia
core  

Current role of catheter ablative procedures in patients with cardiac arrhythmias. A report for health professionals from the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. [PDF]

, 1991
Melvin M. Scheinman, Michael M. Laks, John Dimarco, Vance J. Plumb   +3 more
openalex   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Author Correction: Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice [PDF]

, 2021
Gustavo Monnerat, Micaela López Alarcón, Luiz Ricardo C. Vasconcellos, Camila Hochman-Mendez, Guilherme Visconde Brasil, Rosana A. Bassani, Óscar Casis, Daniela Malan, Leonardo H. Travassos, Marisa Sepúlveda, Juan Ignacio Burgos, Martín Vila Petroff, Fabiano Ferreira, Marcelo T. Bozza, Cláudia N. Paiva, Adriana Bastos Carvalho, Adriana Bonomo, Bernd K. Fleischmann, Antônio Carlos Campos de Carvalho, Emiliano Medei   +19 more
openalex   +1 more source

Risk of cardiac, neuropsychiatric and musculoskeletal adverse events with levothyroxine: Systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Levothyroxine (LT4) is the standard treatment for hypothyroidism and the most widely prescribed medication worldwide. Although generally safe, regulatory reports list potential cardiac, neuropsychiatric and musculoskeletal adverse events (AEs). Clarifying their clinical relevance is essential.
Bala Swetha Baskaran, Mohammad Ali Omrani, Flory T. Muanda   +2 more
wiley   +1 more source

Cardiac resynchronization therapy in heart failure based on Strauss criteria for left bundle branch block

ESC Heart Failure
Aims The left bundle branch block (LBBB) is a strong predictor of response to cardiac resynchronization therapy (CRT). However, a significant number of patients do not respond to the treatment.
Athanasios Saplaouras, Konstantinos Vlachos, Panagiotis Mililis, Athena Batsouli, George Bazoukis, Sotirios Xydonas, Panagioula Niarchou, Antonio Frontera, Stylianos Dragasis, Ourania Kariki, Ilias G. Patsiotis, Aggeliki Gkouziouta, Panagiotis Stachteas, Panagiotis Korantzopoulos, Stylianos Tzeis, Nikolaos Fragakis, Michael Efremidis, Konstantinos P. Letsas   +17 more
doaj   +1 more source

Electrocardiography in horses, part 2: how to read the equine ECG [PDF]

, 2010
The equine practitioner is faced with a wide variety of dysrhythmias, of which some are physiological. The recording of an exercise electrocardiogram (ECG) can help distinguish between physiological and pathological dysrhythmias, underlining the ...
De Clercq, Dominique, Decloedt, Annelies, Deprez, Piet, Sys, Stanislas, van Loon, Gunther, Verheyen, Tinne   +5 more
core